Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Angiogenesis and inflammation in the retinopathy risk of insulin and semaglutide - a review.
Journal: International journal of retina and vitreous
Published: August 28, 2025
Reversing cardiac hypertrophy and heart failure using a cardiac targeting peptide linked to miRNA106a.
Journal: Clinical and translational medicine
Published: October 01, 2024
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
Journal: Journal of hematology & oncology
Published: February 21, 2023
Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
Journal: Journal of hematology & oncology
Published: November 01, 2022
Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
Journal: Journal of hematology & oncology
Published: April 29, 2022
Protective role of AgRP neuron's PDK1 against salt-induced hypertension.
Journal: Biochemical and biophysical research communications
Published: April 15, 2018
Showing 1-7 of 7
Last Updated: 09/26/2026